Alligator Bioscience AB (publ)

SSE:ATORX.ST

1.178 (SEK) • At close February 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) SEK.

2023202220212020201920182017201620152014
Revenue 58.10735.69612.9434.3524.35826.95956.87558.24289.7971.234
Cost of Revenue 218.792147.72586.98282.32145.375121.1623.2042.55331.04344.842
Gross Profit -160.685-112.029-74.039-77.968-141.017-94.20353.67155.687258.754-43.608
Gross Profit Ratio -2.765-3.138-5.72-17.915-32.358-3.4940.9440.9560.893-35.339
Reseach & Development Expenses 264.585134.92668.03869.102132.016102.92160.33539.80549.4942.352
General & Administrative Expenses 0018.94413.21813.35918.24118.6123.47349.33548.605
Selling & Marketing Expenses 0000000000
SG&A 35.8131.21318.94413.21813.35918.24118.6123.47349.33548.605
Other Expenses 104.09193.07267.32366.06872.15457.97840.95829.54839.45228.545
Operating Expenses 300.395227.998154.305148.388217.529179.14119.90392.82688.78777.15
Operating Income -252.777-192.789-141.565-144.298-214.519-153.08-62.299-56.081203.006-77.213
Operating Income Ratio -4.35-5.401-10.938-33.157-49.224-5.678-1.095-0.9630.701-62.571
Total Other Income Expenses Net 4.191-0.614-0.1711.0024.4072.138-0.73-13.776.3670.368
Income Before Tax -248.586-193.403-141.736-143.296-210.112-150.043-63.758-48.356207.377-76.782
Income Before Tax Ratio -4.278-5.418-10.951-32.926-48.213-5.566-1.121-0.830.716-62.222
Income Tax Expense 10.321-0.0060.2310.3130.4192.138-0.7118.3546.3680.369
Net Income -248.586-193.397-141.967-143.609-210.531-150.043-63.758-48.356207.377-76.782
Net Income Ratio -4.278-5.418-10.969-32.998-48.309-5.566-1.121-0.830.716-62.222
EPS -0.55-0.88-0.96-1.22-1.57-1.12-0.48-0.431.87-0.58
EPS Diluted -0.55-0.88-0.96-1.22-1.57-1.12-0.48-0.431.58-0.58
EBITDA -242.288-180.996-130.361-131.461-198.145-144.131-60.535-1.557220.045-73.595
EBITDA Ratio -4.17-5.07-10.072-30.207-45.467-5.346-1.064-0.0270.759-59.639